BMY
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company 13F Holders
BMY Stock Ownership Activity
- # of activities:
- 6
- AVG reported price*:
- $45.10
- Current price*:
- +36.14%($61.40)
6 value investing gurus have made changes to the Bristol-Myers Squibb Company (BMY) position according to the gurus' 2025 Q3 SEC quarterly report(s). The number of BMY shares has been increased by 3, decreased by 3 super investor(s).
Which gurus or hedge funds bought BMY in 2025 Q3?
According to the 2025 Q3 SEC filing(s) Bristol-Myers Squibb Company (BMY) has been bought by 3 gurus / funds: Independent Franchise Partners - US Equity Fund (added shares +5.22%), Eric H. Schoenstein - Jensen Investment Management (added shares +0.38%) and Tweedy, Browne Co All Funds (US) (added shares +101.36%).
To see more about who is investing in Bristol-Myers Squibb Company (BMY), please go to the BMY ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.